Artivion, Inc. Common Stock (NY:AORT)
All News about Artivion, Inc. Common Stock

This Analyst Says Artivion's Sell Off Seems Overdone After Trial Halt
September 26, 2022
Via Benzinga

Oppenheimer Maintains Outperform Rating for Artivion: Here's What You Need To Know
September 26, 2022
Via Benzinga



$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
September 23, 2022
Via Benzinga


Artivion Stock Plunges Apixaban Vs. Warfarin Trial Setback, Reaffirms Annual Guidance
September 23, 2022
Via Benzinga





Via Benzinga



Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free